financetom
Business
financetom
/
Business
/
EXPLAINER-ECB's role in any UniCredit and Commerzbank combination
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EXPLAINER-ECB's role in any UniCredit and Commerzbank combination
Sep 22, 2024 3:58 AM

FRANKFURT, Sept 19 (Reuters) - UniCredit, Italy's

second-largest bank, has taken a 9% stake in Germany's

Commerzbank and is seeking permission to potentially raise this

to 29.9%, sources told Reuters, while saying it would be open to

a full takeover bid.

For UniCredit to raise its Commerzbank

stake above 10% will, however, need approval from the European

Central Bank, the supervisor of the euro zone's biggest banks.

Here is a summary of the ECB's role in the process.

WHEN DOES ECB STEP IN?

ECB approval is required if a shareholder wants to acquire

10% or more in a supervised lender. There are additional

thresholds at 20%, 30% and 50%. A buyer, however, can apply to

acquire any stake, so it can skip interim reviews if it is

cleared already for a larger stake.

WHAT DOES THE ECB EXAMINE?

UniCredit will have to tell the ECB its ultimate aim and

supervisors will evaluate its proposal in light of this.

It examines factors such as the buyer's reputation, the

quality of board members it would appoint, the buyer's financial

health and the ability of the target to comply with supervisory

requirements.

The criteria give some leeway, but essentially the ECB would

have to decide if UniCredit could afford to buy Commerzbank and

remain financially sound, and if it would form a stronger group.

UniCredit is a capital-rich bank with plenty of cash and

solid profitability. It has a common equity tier 1 (CET1)

capital ratio of 16.2%, well above its target of 12.5%-13.0%

despite a generous dividend and share buy-back programme.

WOULD THE ECB SUPPORT A MERGER?

It is hard to say without knowing UniCredit's specific

objectives. But there are clues suggesting that if structured in

the right way, the ECB could support it.

The ECB has repeatedly said that cross border mergers are

desirable given inefficiency and high costs in the euro zone

bank sector. Euro zone banks are also falling behind their far

larger U.S. peers.

"Cross-border mergers have been hoped for by many

authorities, and it will be very interesting to see that process

unfold in the weeks to come," ECB President Christine Lagarde

said last week.

Bundesbank chief Joachim Nagel has so far been rather

neutral, but has outlined requirements for support.

"We need strong and robust banks so that companies can

tackle and finance their future tasks," Nagel said this week.

"In case of possible mergers, it is important that a

competitive institution is created which fulfils this task as

best as possible."

WHAT DO PREVIOUS MERGERS TELL US?

In the biggest bank deal so far this year, the ECB approved

a 12 billion euro ($13.4 billion) bid by BBVA to buy smaller

Spanish rival Sabadell, only to see the deal blocked

by Spain's government.

Winning over the ECB may not be the biggest hurdle that

UniCredit would face, a takeover of Commerzbank would have deep

political implications as it would see Germany, Europe's largest

economy, cede control of its second-largest bank.

HOW LONG IS THE PROCESS?

The ECB has 60 days to approve a request and this could be

extended by 30 days. The process usually takes the bulk of this

time, so no quick decision is likely.

WHO MAKES THE DECISION?

The ECB supervisory board, with representatives from all

euro zone members, must sign off on any deal and the

rate-setting Governing Council would also get to look in a

non-objection procedure.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved